OOIR: Observatory of International Research

Papers

(The median citation count of Heart Rhythm is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Implantable cardioverter-defibrillators for primary prevention during or early after hospitalization? A time to pause, reflect, and exercise sound clinical judgment	443
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection	209
Decisional conflict and defibrillator implantation choices among Black women and men with chronic systolic heart failure	177
Outcome of cardiac implantable electronic devices in pediatric heart transplant recipients	142
To the Editor — Ganglionated plexus modulation inducing vagal response during pulsed field ablation for atrial fibrillation: A blessing in disguise	131
Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial	123
PO-01-181 A TOPSY TURVY CASE OF GADOLINIUM-BASED CONTRAST AGENT INDUCED QTC PROLONGATION AND TORSADES DE POINTES	117
MP-470544-008 AV MIRRORING IN SILICONE PACING LEADS WITH TRIBOLOGICAL WEAR – A CASE SERIES	110
PO-07-021 ARTIFICIAL-INTELLIGENCE BASED TRACKING OF ATRIAL FIBRILLATION WAVES TO IDENTIFY SITES OF ACUTE ABLATION SUCCESS	99
Alert notifications for impending patient demise—Widening the powers of automatic remote monitoring of cardiac implantable electronic devices	92
Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?	86
PO-04-066 DESIGN AND PRE-CLINICAL ASSESSMENT OF A NOVEL RETROGRADE AORTIC DELIVERY SHEATH TO AID ACCESS FOR LEFT VENTRICULAR MAPPING AND ABLATION	85
PO-04-170 AUTOMATED CT-BASED PREDICTION OF VENTRICULAR ARRHYTHMIA	83
CI-452767-3 MACHINE LEARNING-POWERED, DEVICE-EMBEDDED HEART SOUND MEASUREMENT CAN OPTIMIZE AV DELAY IN CRT PATIENTS	67
PO-03-146 PREMATURE VENTRICULAR CONTRACTIONS IN CHILDREN AND YOUNG ADULTS: RISK FACTORS FOR LEFT VENTRICULAR DYSFUNCTION	67
PO-02-216 SEGMENTAL INCREASE IN HETEROGENEITY OF REPOLARIZATION CORRESPONDS TO REGIONS OF DECREASED INNERVATION AFTER MYOCARDIAL INFARCTION	66
PO-04-196 CORRELATION BETWEEN VENTRICULAR TACHYCARDIA CIRCUIT AND CARDIAC COMPUTED TOMOGRAPHY-DERIVED WALL THINNING FOR POSTINFARCTION VENTRICULAR TACHYCARDIA ABLATION	56
PO-05-119 PEAK FREQUENCY CAN BE EFFECTIVELY USED TO CHARACTERIZE ATRIAL REMODELING IN ATRIAL FIBRILLATION	56
PO-01-043 COMPARISON OF RISK SCORES FOR PREDICTION OF SUDDEN DEATH AND SUSTAINED VENTRICULAR TACHYCARDIA IN REPAIRED TETRALOGY OF FALLOT	56
PO-01-141 REAL LIFE EXPERIENCE WITH PULSED FIELD ABLATION FOR RECURRENT VENTRICULAR ARRHYTHMIAS	55
PO-01-065 DECREASE IN HEART RATE AND BRADYCARDIA PRECEDING IN-HOSPITAL CARDIAC ARREST	53
PO-04-122 PULSED FIELD ABLATION DOSE-RESPONSE SAFETY AND EFFICACY CHARACTERIZATION OF A NOVEL LARGE SPHERICAL TIP MAPPING AND CONTACT FORCE-SENSING CATHETER	52
PO-01-019 VASCULAR AGE PREDICTION USING CHEST X-RAYS	52
PO-04-064 INVASIVE HAEMODYNAMIC ASSESSMENT SHOWS THE OBESITY-HFPEF PHENOTYPE IS COMMON AMONGST PATIENTS WITH SYMPTOMATIC AF	51
PO-03-160 IS THERE A FUTURE FOR THE 90-DAY BLANKING PERIOD AFTER PULSED FIELD ABLATION: EARLY RECURRENCES IN THE PULSED AF TRIAL	51

PO-01-079 SEX DIFFERENCES IN ELECTROGRAPHIC FLOW PHENOTYPES AND OUTCOMES IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION	47
PO-01-093 PREDICTORS OF ARRHYTHMIA IN THE INPATIENT POPULATION PRIMARILY HOSPITALIZED FOR SARS-COV-2; A RETROSPECTIVE LARGE-DATABASE ANALYSIS	45
PO-01-026 RIGHT ATRIAL APPENDAGE THROMBECTOMY USING ALPHAVAC TO FACILITATE ATRIAL FIBRILLATION (AFIB) ABLATION	45
PO-02-144 LEFT ATRIAL FUNCTIONAL AND TISSUE CHANGES AFTER PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION PATIENTS - INITIAL RESULTS OF THE EVALUATE-PVI STUDY	44
PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE	43
PO-02-140 WITHDRAWN	43
MP-483499-007 MECHANISMS OF MITRAL ISTHMUS RECONNECTION AFTER MITRAL ISTHMUS ABLATION WITH AND WITHOUT VEIN OF MARSHALL ETHANOL INFUSION	42
PO-03-171 LEADLESS PACEMAKERS ARE UNAFFECTED BY RADIATION EXPOSURE AT CLINICALLY RELEVANT THERAPEUTIC DOSES USED IN ONCOLOGY	40
PO-03-192 THE ASSOCIATION BETWEEN PACED LEFT VENTRICULAR ACTIVATION TIME AND CARDIAC REVERSE REMODELING IN HEART FAILURE PATIENTS WITH LEFT BUNDLE BRANCH BLOCK	40
PO-02-192 FIRST REPORT OF STRENGTH-DURATION CURVES OBTAINED FROM PATIENTS IMPLANTED WITH A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM	39
PO-02-064 IS THORACIC IMPEDANCE TRULY ACCURATE IN PREDICTING ACUTE DECOMPENSATIONS ACROSS DIFFERENT STAGES OF HEART FAILURE?	38
PO-03-164 INCIDENCE, PREDICTORS, AND INDICATIONS FOR PERMANENT PACEMAKER IMPLANTATION AFTER ORTHOTOPIC HEART TRANSPLANTATION	37
PO-02-069 OUTCOMES OF LEFT BUNDLE BRANCH AREA PACING UPGRADE IN PATIENTS WITH RIGHT VENTRICULAR PACING-INDUCED CARDIOMYOPATHY	36
PO-01-036 ACCURACY OF FORWARD-SOLUTION COMPUTATIONAL ECG MAPPING FOR VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ADULT CONGENITAL HEART DISEASE	36
MP-483492-003 SHORTER COUPLED PREMATURE ATRIAL COMPLEXES LEAD TO ACUTE ATRIAL MECHANICAL DYSFUNCTION AND CHRONIC INDUCIBLE ATRIAL FIBRILLATION IN A SWINE MODEL	35
MP-483493-004 SUPERIORITY OF LONG-DURATION RADIOFREQUENCY ABLATION TO THE USE OF HALF-NORMAL SALINE IRRIGATION IN INCREASING LESION SIZE	35
PO-02-184 IMCAP-AI STUDY: EVALUATION OF THE DIAGNOSTIC PERFORMANCE AND ORGANIZATIONAL IMPACT OF AN ILR ECG ANALYZER ALGORITHM IN CLINICAL PRACTICE	35
MP-470554-005 VERY SLOW ATRIOVENTRICULAR NODE REENTRY TACHYCARDIA MASQUERADING AS JUNCTIONAL RHYTHM: MECHANISM AND ELECTROPHYSIOLOGIC CHARACTERISTICS	35
PO-06-072 BIPOLAR ABLATION FOR SEPTAL VENTRICULAR TACHYCARDIA IN A PATIENT WITH CARDIAC SARCOIDOSIS	34
PO-06-117 CLINICAL OUTCOMES OF PROSPECTIVE COMPUTATIONAL 12-LEAD ECG MAPPING GUIDED PVC ABLATION	34
PO-06-125 ZERO-FLUOROSCOPY CATHETER ABLATION IN PREGNANT: EVALUATION OF SAFETY, FEASIBILITY AND EFFICACY	34
PO-02-081 EXPLORING THE ROLE OF HEART-TORSO GEOMETRY IN NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING ACCURACY AND POTENTIAL GEOMETRIC CALIBRATION TECHNIQUES	33
Anatomy terminology—Note from the Editors	33
PO-03-121 THE EFFECT OF DIAGNOSIS TO ABLATION TIME IN PATIENTS UNDERGOING CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION	33
PO-02-156 THE RISE OF LEFT BUNDLE BRANCH AREA "PACE AND ABLATE"; AV NODAL ABLATION OUTCOMES, WHERE ARE WE NOW?	32
PO-01-180 MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION-INDUCED ATRIAL FIBRILLATION IN THE RIGHT HEART: INSIGHTS FROM MULTI-SCALE MODELS OF THE HUMAN ATRIA	32
PO-05-106 THREE-DIMENSIONAL INTRACARDIAC ECHOCARDIOGRAPHY TO GUIDE LEFT ATRIAL APPENDAGE AND PERI-DEVICE LEAK CLOSURE: FEASIBILITY OF RIGHT-SIDED IMAGING	32
MP-453092-7 THE IMPACT OF ELECTROANATOMICAL MAPPING AND VT SUBSTRATE ABLATION ON PRIMARY AND SECONDARY PREVENTION ICD INDICATION IN PATIENTS WITH REPAIRED TETRALOGY OF FALLOT	32
PO-01-103 IMPACT OF FILTERED IMPEDANCE DROP ON ATRIAL LESION SIZE PREDICTION	32
MP-453089-5 CLINICAL BENEFITS OF EARLY LEFT BUNDLE BRANCH PACING IN HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION AND LEFT BUNDLE BRANCH BLOCK	32
Predicting decline in left ventricular function after new-onset left bundle branch block	32
Defining the holy grail of left bundle branch area pacing—does the pulse width matter?	31
PO-02-192 OUTCOMES OF LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH HEART FAILURE: A 5-YEAR PROPENSITY MATCHED ANALYSIS	31
Diltiazem, direct oral anticoagulants, and risk of major bleeding in patients with atrial fibrillation	31
PO-FP-083 ARRHYTHMIC EVENT RISK AND NEONATAL OUTCOMES IN PREGNANT AND POSTPARTUM CPVT PATIENTS	31
PO-02-081 REDUCTION IN ARIAL TACHYCARDIA/ATRIAL FIBRILLATION IN SUSTAINED ATRIAL FIBRILLATION PATIENTS AFTER ATRIOVENTRICULAR JUNCTION ABLATION: A RETROSPECTIVE REAL-WORLD ANALYSIS	31
Reply to the Editor — Risk of atrial arrhythmias in arrhythmogenic right ventricular cardiomyopathy patients undergoing ventricular tachycardia ablation	31
PO-01-146 SUCCESSFUL MANAGEMENT OF MULTIFOCAL ATRIAL TACHYCARDIA WITH TRAMETINIB IN COSTELLO SYNDROME	31
PO-05-200 FEASIBILITY AND ACCEPTABILITY OF A SELF-CARE INTERVENTION FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PATIENTS: A “SYSTEMS CHECK”	31
HF-499653-005 CHARACTERIZATION OF RIGHT BUNDLE BRANCH BLOCK WITH INVASIVE MAPPING: IMPLICATIONS FOR CONDUCTION SYSTEM PACING	30
PO-01-064 CONDUCTION SYSTEM PACING TO RESYNCHRONIZE AND IMPROVE THE SYSTOLIC PERFORMANCE OF THE SYSTEMIC RIGHT VENTRICLE IN A PATIENT WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	30
PO-01-103 PFA TO THE RESCUE: TERMINATION OF RF RESISTANT RVOT VT WITH A SINGLE PFA APPLICATION	30
PO-02-038 LACK OF ATRIAL BRANCH PERFUSION DURING ACUTE ISCHEMIA IS NOT ASSOCIATED WITH NEW-ONSET ATRIAL FIBRILLATION DURING STEMI	30
PO-05-076 GENETIC DEPENDENCY OF ATRIAL FIBRILLATION-ASSOCIATED RISK GENES ACROSS TISSUE TYPES: DISCOVERING NOVEL THERAPEUTIC TARGETS	30
PO-02-088 THE IMPACT OF POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY	29
PO-04-016 CALCULATION OF LOADING DOSE OF HEPARIN DURING ATRIAL FIBRILLATION ABLATION IN PATIENTS RECIEVING UNINTERRUPTED DIRECT ORAL ANTICOAGULANT AGENTS	29
EN-499638-002 PHARMACOLOGIC RESCUE OF LOSS-OF-FUNCTION CARDIAC SODIUM CHANNELOPATHIES	29
PO-04-028 PULSED FIELD ABLATION FOR PULMONARY VEIN ISOLATION WITH OR WITHOUT POSTERIOR WALL ISOLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A MULTICENTER RETROSPECTIVE STUDY	29
PO-05-214 THE RELATIONSHIP BETWEEN WIDE ANTRAL CIRCUMFERENTIAL ABLATION LINE LENGTH AND RECURRENCE OF ATRIAL FIBRILLATION POST-PULMONARY VEIN ISOLATION	29
PO-05-031 CARDIAC SYMPATHETIC NEUROPATHOLOGY SUPPORTS THE MULTICELLULARITY OF ARRHYTHMOGENIC CARDIOMYOPATHY	28

PO-CES-01 OPTOGENETICS FOR INVESTIGATION OF ARRHYTHMIA MECHANISMS AND TREATMENTS IN A HUMANIZED RECELLULARIZED ATRIAL MODEL	28
PO-FP-023 ASSOCIATIONS BETWEEN DEVICE-MEASURED 24-HOUR MOVEMENT BEHAVIORS AND CARDIAC CONDUCTION DISEASE IN THE UK BIOBANK: A PROSPECTIVE COHORT STUDY	28
PO-04-145 IMPACT OF TIME FROM ATRIAL FIBRILLATION DIAGNOSIS TO ABLATIVE THERAPY ON DEATH AND HOSPITALIZATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS BY AGE AND SEX FROM THE INTERMOU	28
PO-05-132 SGLT2 INHIBITORS ATTENUATE ATRIAL CARDIOMYOPATHY AND REDUCE AF SUSCEPTIBILITY IN NPPA KNOCK-IN RATS	28
PO-05-020 ARTERIAL BAROREFLEX DESENSITIZATION IS THE MECHANISM OF SYMPATHETIC OVERLOAD AND PARASYMPATHETIC SUPPRESSION IN PREMATURE VENTRICULAR CONTRACTION-INDUCED CARDIOMYOPATHY	28
PO-04-170 WITHDRAWN	28
PO-02-044 EFFICACY AND DRUG-RELATED COMPLICATIONS OF ANTICHOLINERGIC DRUGS FOR VAGAL REACTION PREVENTION DURING PULSED FIELD ABLATION	27
PO-02-017 POSTPARTUM DIRECT ORAL ANTICOAGULANTS OR ASPIRIN IN PREGNANT WOMEN WITH ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED ANALYSIS	27
PO-07-031 UNCOVERING WHAT IS RIGHT IN FRONT OF US: QDOT MICRO™ FOR ACCESSORY PATHWAY ABLATION	27
PO-07-035 DEEP LEARNING-BASED PREDICTION OF AVNRT ABLATION TARGETS FROM INTRACARDIAC ELECTROGRAMS	27
PO-02-201 LONG-TERM USE OF ORAL ANTICOAGULATION AFTER WATCHMAN IMPLANTATION	27
PO-03-073 1-YEAR AND 3-YEAR OUTCOME COMPARISON BETWEEN RADIOFREQUENCY AND CRYOBALLOON ABLATION IN ATRIAL FIBRILLATION	27
PO-04-010 TEMPORAL SEQUENCE OF OBSTRUCTIVE SLEEP APNEA AND ATRIAL FIBRILLATION DEVELOPMENT IMPACTS THE PROGNOSIS AND THE INCIDENCE OF MAJOR CARDIOVASCULAR EVENTS	27
PO-03-081 VISUALIZATION AND CHRONIC ASSESSMENT OF ELECTRICAL FIELD TAGS FOR PULSED FIELD ABLATION OF PULMONARY VEINS WITH THE SECOND-GENERATION PENTASPLINE CATHETER	27
PO-06-128 SHORT-TERM OUTCOMES AND PERFORMANCE OF DUAL-CHAMBER LEADLESS PACEMAKERS: A SINGLE-CENTRE EXPERIENCE WITH 60 PATIENTS	27
PO-06-070 CURRENT OF INJURY ON THE RIGHT VENTRICULAR ENDOCARDIUM BEFORE ENTRAPMENT OR SUCCESSFUL PLACEMENT OF THE LEFT BUNDLE BRANCH AREA PACING LEAD	26
PO-02-118 CLUSTERING BASED ON CARDIAC AND BRAIN CENTRAL AUTONOMIC NETWORK DATA STRATIFIES ATRIAL FIBRILLATION PATIENTS BY COMORBID DEPRESSION AND STROKE RISK	26
PO-07-107 CRYOBALLON PULMONARY VEIN ISOLATION (PVI) IN SITUS AMBIGUOUS AND DEXTROCARDIA	26
PO-06-006 HIGH ATRIAL SEPTAL IMPLANTS DEMONSTRATE REDUCED ACUTE INACTIVATION RATES AND IMPROVED AV CONDUCTION WHEN COMPARED TO APPENDAGE IMPLANTS	25
PO-07-070 STELLATE GANGLION BLOCK IN THE MANAGEMENT OF EMERGENT VENTRICULAR ARRHYTHMIAS: OUTCOMES FROM A SINGLE CANADIAN CENTER	25
PO-06-033 LONG-TERM OUTCOMES OF TRIPLE-SITE VERSUS DUAL-SITE CARDIAC RESYNCHRONIZATION THERAPY USING TEMPORARY PACING TO GUIDE INDIVIDUALIZED IMPLANTATION	25
PO-06-203 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FAILURE DUE TO HIGH-VOLTAGE IMPEDANCE ABNORMALITY CAUSING MONOPHASIC SHOCKS AND DEFIBRILLATION FAILURE	25
PO-06-032 LV SIZE: AN ANONYMOUS MODULATOR OF ELECTRICAL OPTIMIZATION IN CRT	25
PO-03-208 COMPARISON OF LESION FORMATION WITH TEMPERATURE CONTROLLED ABLATION USING QDOT CATHETER	24
PO-06-191 PREDICTORS OF PACEMAKER DEPENDENCY FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION	24
PO-06-090 THE INCIDENCE OF FAILURE OF REMAINING FUNCTIONAL LEADS AND NEWLY IMPLANTED LEADS AFTER TRANSVENOUS LEAD EXTRACTION	24
PO-07-064 STELLATE GANGLION BLOCK AS AN ADJUNCT TREATMENT OF DRUG-REFRACTORY ELECTRIC STORM: A PERSPECTIVE OF A TERTIARY CENTER	24
PO-03-051 EXPEDITED SAME DAY DISCHARGE PROTOCOL IS SAFE FOR PATIENTS UNDERGOING CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) IMPLANTATION	23
EP News: Pediatric and Congenital Electrophysiology	23
Atrial fibrillation’s hidden compass: The left atrium and the future of risk stratification	23
PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING	23
MP-470551-004 EARLY ROLE OF NEUTROPHILS IN THE PATHOGENESIS OF ARRHYTHMOGENIC CARDIOMYOPATHY	23
Supraventricular tachycardia with double trouble	23
Fifty years later, I was the recipient of the medical innovation I invented	23
EP News: Pediatric and Congenital Electrophysiology	23
CI-482892-002 DEFIBRILLATION SUCCESS WITH A SECOND GENERATION INTERCOSTAL EXTRAVASCULAR ICD LEAD AND COMMERCIALLY AVAILABLE LEFT PECTORAL PULSE GENERATORS	23
PO-03-158 PEDIATRIC CARDIAC SCREENING DATA WAREHOUSE: A NATIONAL PUBLIC HEALTH RESOURCE	23
PO-04-144 IMPACT OF AGE ON ATRIAL ARRHYTHMIA OUTCOMES AFTER PERCUTANEOUS ASD CLOSURE	23
Leadless pacing after transvenous lead extraction: Are we out of the woods?	23
PO-03-026 ACUTE PROCEDURAL AND INTERMEDIATE-TERM LEAD PERFORMANCE OF LEFT BUNDLE BRANCH AREA PACING	22
PO-03-007 CROSS VALIDATION OF A MACHINE LEARNING ALGORITHM DESIGNED TO IDENTIFY PULMONARY VEIN SIGNALS USING COMPETING TRAINING DATA	22
PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION	22
PO-05-012 REPOLARIZATION CHANGES FOLLOWING CONDUCTION SYSTEM PACING EVALUATED BY ULTRA-HIGH-FREQUENCY ELECTROCARDIOGRAPHY	22
PO-03-094 IMAGE INTEGRATION IN VENTRICULAR TACHYCARDIA (VT) ABLATION USING SENSE2 PROTOCOL MAPPING	22
Unusual responses of a short RP tachycardia to His-refractory ventricular premature depolarizations: What is the mechanism?	22
PO-04-033 CARDIONEUROABLATION IN A WOMAN WITH ICTAL-INDUCED CARDIAC ASYSTOLE	22
PO-04-110 MAPPING TRENDS IN AVNRT ABLATION: AN INTERNATIONAL ANALYSIS	22
PO-03-222 CURRENT TRENDS AND OUTCOMES OF SUDDEN CARDIAC ARREST IN YOUNG ADULTS IN THE USA: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE	22
Wide complex tachycardia with atrioventricular dissociation? Not so fast buddy	22
AP-452680-5 SPEECH-INDUCED ATRIAL TACHYCARDIA: A RARE PHENOMENON DOCUMENTED DURING PACEMAKER DEVICE INTERROGATION	22
PO-04-092 SAFETY AND EFFICACY OF DIFFERENT FIELD STRENGTHS OF PULSED-FIELD ABLATION IN ACHIEVING DURABLE CAVOTRICUSPID ISTHMUS BLOCK: A PRECLINICAL STUDY	22
PO-02-089 EMPIRIC VEIN OF MARSHALL ETHANOL INFUSION IN PATIENTS UNDERGOING REPEAT CATHETER ABLATION WITH DURABLY ISOLATED PULMONARY VEINS	22
PO-02-224 CONDUCTION VELOCITIES DETERMINED BY NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING PREDICT ARRHYTHMIA-FREE SURVIVAL AFTER PULMONARY VEIN ISOLATION	22
PO-03-055 INCIDENCE OF INAPPROPRIATE PAUSE DETECTION WITH REMOTE CARDIAC MONITORING BY INSERTABLE CARDIAC MONITOR, A REAL-WORLD STUDY	22
PO-03-015 HIS BUNDLE PACING: OUTCOME AFTER 10-YEARS FOLLOW-UP	22
Table of Contents	21
A troubling tachycardia	21
Artificial intelligence for detection of ventricular oversensing: Machine learning approaches for noise detection within nonsustained ventricular tachycardia episodes remotely transmitted by pacemaker	21
Association between modifiable risk factors and bradyarrhythmia: A Mendelian randomization study	21
PO-02-151 INCREASED VENTRICULAR ARRHYTHMIAS IN A MOUSE MODEL OF HYPERTROPHIC CARDIOMYOPATHY	21
PO-02-047 OUTCOMES OF CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE REMOVAL WITHOUT REIMPLANTATION IN PEDIATRIC PATIENTS	21
PO-02-175 AI ENABLES SIGNIFICANT REDUCTION OF CLINIC REVIEW BURDEN FOR LEGACY ICMS	21
PO-03-138 REAL-WORLD EXPERIENCE UTILIZING THE NUVISION 4D INTRACARDIAC ECHOCARDIOGRAPHY CATHETER FOR LEFT TRIAL APPENDAGE CLOSURE	21
PO-04-233 MULTIDISCIPLINARY APPROACHES TO TREAT VENTRICULAR ARRHYTHMIAS WITH RADIOABLATION AND CARDIAC SYMPATHECTOMY (MAVERICS)	21
Novel electrocardiographic observations during left bundle branch area pacing: Multiple QRS transition, supernormality, concealed capture, virtual electrode effect, and other phenomena	21
Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension	21
Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases	20
Empirical slow pathway ablation in patients with paroxysmal palpitations and pounding in the neck: A 15-year follow-up	20
Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration	20
PO-05-310 SOCIODEMOGRAPHIC AND GENDER DISPARITIES IN ATRIAL FLUTTER ABLATION RATES: A NATIONWIDE STUDY OF THE USA	20
Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-bli	20
Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes	20
PO-01-205 LEFT LATERAL PULSE GENERATOR PLACEMENT RECOMMENDATIONS FOR THE PARASTERNAL EV-ICD SYSTEM	20
PO-04-255 TRAMETINIB AS POTENTIAL OFF-LABEL THERAPY TO PREVENT DISEASE IN A MOUSE MODEL OF SARCOMERIC HYPERTROPHIC CARDIOMYOPATHY	20
Atrial resynchronization with Bachmann bundle pacing—time to think outside the appendage?	20
Access to electrophysiologic care for Medicare beneficiaries across the United States: Travel distance and time to nearest clinician, 2013–2020	20
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement	20
PO-FPI-294 IMPACT OF ORAL ANTICOAGULANT DISCONTINUATION ON QUALITY OF LIFE IN PATIENTS AFTER SUCCESSFUL ATRIAL FIBRILLATION ABLATION: RESULTS FROM THE ALONE-AF TRIAL	20
PO-FPI-016 PROGNOSTIC SIGNIFICANCE OF AF BURDEN QUANTIFIED BY CONTINUOUS REMOTE MONITORING IN PATIENTS WITH CARDIAC IMPLANTABLE DEVICES	19
CE-534534-005 LONG-TERM PERFORMANCE OF DIFFERENT TREATMENT APPROACHES IN BRUGADA SYNDROME	19

PO-04-029 VERY HIGH POWER VS. HIGH POWER SHORT DURATION CATHETER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION – PROCEDURAL RESULTS FROM A RANDOMIZED TRIAL	19
PO-04-149 SAFETY AND CLINICAL OUTCOMES OF AN INDEX ENDO-EPICARDIAL STRATEGY, UTILISING EPICO2,FOR ANTIARRHYTHMIC RESISTANT VENTRICULAR ARRHYTHMIAS	19
PO-FPII-311 LEAD V8 AS A SIMPLE NON-INVASIVE TOOL FOR ASSESSING LV ACTIVATION DELAY AND GUIDING LEAD PLACEMENT ACROSS CONDUCTION ABNORMALITIES	19
PO-05-324 ONE YEAR FOLLOW UP COSTS OF RF VS. PFA FOR ATRIAL FIBRILLATION ABLATION	19
PO-03-012 PATIENT-LEVEL OPTIMIZATION OF LOOP RECORDER TRANSMISSIONS: A LONGITUDINAL ANALYSIS OF 26 PATIENTS ACHIEVING 71% REDUCTION	19
PO-CES-01 PANORAMIC OPTICAL AND VOLUMETRIC ULTRASOUND IMAGING OF ELECTROMECHANICS IN CONTRACTING HEARTS	19
PO-02-244 SILENCING THE VAGUS: INTRACARDIAC ECHO GUIDED CARDIONEUROABLATION FOR MALIGNANT BRADYCARDIA AFTER TRAUMATIC BRAIN INJURY	19
PO-03-304 INTRACARDIAC ELECTROGRAM RECORDING OF BACHMANN'S BUNDLE DURING INTERMITTENT INTERATRIAL BLOCK IN A PATIENT WITH VARYING P WAVE MORPHOLOGIES: LOCALIZING THE SITE OF INTERATRIAL CONDUCTION DEL	19
PO-03-267 FEASIBILITY AND SHORT-TERM OUTCOMES OF DISTAL HIS BUNDLE PACING	19
PE-534543-001 FEASIBILITY OF A MODIFIED MINIATURE DUAL CHAMBER EPICARDIAL PACING SYSTEM FOR PEDIATRIC USE	18
PO-03-063 NOVEL SOFTWARE PLATFORM UTILIZES IMPLANTABLE CARDIAC MONITOR SECGS FOR EXTENDED QTC AND RHYTHM SURVEILLANCE IN AF PATIENTS ON ANTIARRHYTHMIC DRUGS: A CLINICAL PILOT	18
PO-05-269 POST-ABLATION SCAR BURDEN DISCRIMINATES RECURRENCE PATTERN: ATRIAL FLUTTER VS ATRIAL FIBRILLATION	18
PO-02-186 VENTRICULAR ARRHYTHMIA ORIGINATING FROM THE EPICARDIAL ASPECT OF THE RIGHT VENTRICULAR APEX: A CASE REPORT	18
PO-04-013 NATIONWIDE SAFETY ASSESSMENT OF OVER 20,000 PULSED FIELD AND 10,000 THERMAL ABLATIONS FOR ATRIAL FIBRILLATION IN THE UNITED STATES	18
PO-05-276 PROCEDURAL & CLINICAL OUTCOMES OF ADDITIONAL ATRIAL ARRHYTHMIAS ABLATED DURING PULSED FIELD ABLATION OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION	18
PO-03-235 OUTCOMES OF CONDUCTION SYSTEM PACING IN COMPLETE HEART BLOCK: EVIDENCE FROM A LARGE REAL-WORLD COHORT	18
PO-05-038 ANTI-INFLAMMATORY AND AUTONOMIC EFFECTS OF BAROREFLEX ACTIVATION THERAPY IN HFREF: A CASE SERIES	18
PO-03-061 PREDICTION OF ATRIAL FIBRILLATION FROM 10-SECOND AND 60-SECOND AMBULATORY ECG SEGMENTS USING A SELF-SUPERVISED FOUNDATIONAL MODEL	18
PO-04-254 A HUMAN IPSC-DERIVED SINOATRIAL NODE ORGANOID MODEL RECAPITULATES FIBROSIS-DRIVEN SICK SINUS SYNDROME AND IDENTIFIES TANSHINONE IIA AS A POTENTIAL THERAPEUTIC AGENT	18
PO-04-293 SAFETY AND EFFICACY OF ANTITHROMBOTIC THERAPY WITH LOW-DOSE APIXABAN AFTER WATCHMAN FLX LEFT ATRIAL APPENDAGE OCCLUSION DEVICE IMPLANTATION	18
PO-01-041 SAFETY OF THE USE OF THE VARIABLE LOOP CIRCULAR CATHETER FOR PATIENTS WITH ATRIAL FIBRILLATION AND CARDIAC DEVICES	18
PO-03-197 THE COMPETING RISK OF ARRHYTHMIC EVENTS AND NON-ARHYTHMIC MORTALITY BY AGE: ANALYSIS FROM THE APPRAISE-ATP TRIAL	18
PO-01-254 REAL WORLD DATA OF CARDIAC RESYNCHRONIZATION THERAPY AMONG MID-RANGE QRS DURATION USING THE JPN-CRT DATA IN ASIA	18
PO-FPI-017 ESTIMATING APNEA HYPOPNEA INDEX USING ECG AND DEEP NEURAL NETWORKS	18
PO-02-101 NUMBER NEEDED TO ENTRAIN AND PROXIMITY TO VENTRICULAR TACHYCARDIA RE-ENTRANT CIRCUITS	17
PO-04-120 CATHETER ABLATION OF VENTRICULAR TACHYCARDIAS IN STRUCTURAL HEART DISEASE USING A DUAL-ENERGY LATTICE-TIP FOCAL CATHETER	17
PO-01-009 SAFETY OF PULSED FIELD ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES: INSIGHTS FROM THE PROSPECTIVE MULTICENTER DISRUPT-AF REGISTRY	17
PO-01-331 A PROSPECTIVE MULTICENTER STUDY OF MAPPING AND ABLATION OF FOCAL DRIVERS IN REPEAT ATRIAL FIBRILLATION ABLATION	17
PO-02-047 HIGHER DIETARY FIBER INTAKE IS ASSOCIATED WITH LOWER RESTING HEART RATE AND REDUCED TACHYCARDIA PREVALENCE IN U.S. ADULTS: ANALYSIS OF NHANES 2017–2018	17
PO-03-119 EARLY VENTRICULAR ARRHYTHMIA RISK AFTER ACUTE PERICARDITIS: A PROPENSITY MATCHED COHORT ANALYSIS	17
PO-02-035 RIGHT ATRIAL CARDIOMYOPATHY AS THE DOMINANT STRUCTURAL PREDICTOR OF AF RECURRENCE AFTER ABLATION	17
PO-04-022 COMPREHENSIVE RESULTS FROM AN ITERATIVE FIRST-IN-HUMAN INTEGRATED INTRACARDIAC ECHOCARDIOGRAPHY TRIAL	17
PO-05-017 A MASSIVE STEMI: OR A CATASTROPHIC CONSEQUENCE TO ABLATION?	17
PO-02-332 ELEVATED IGE IS ASSOCIATED WITH ATRIAL FIBRILLATION AND PROMOTES CARDIAC SYMPATHETIC REMODELING: A TRANSLATIONAL STUDY	17
PO-03-213 CLINICAL IMPACT OF LEADLESS PACEMAKER IMPLANTATION ON TRICUSPID REGURGITATION	17
PO-03-071 GLP-THERAPY USE AND LOWER BRADYCARDIA RISK IN DIABETES: INSIGHTS FROM A LARGE REAL-WORLD COHORT	17
PO-01-209 TRICUSPID VALVE FUNCTION AFTER HELIX-FIXATION LEADLESS PACEMAKER IMPLANTATION: A SINGLE-CENTER EXPERIENCE	17
PO-02-288 ADVANCED AGE PROMOTES ATRIAL ECTOPY AND ATRIAL FIBRILLATION STABILIZATION: THE ROLE OF ACTIVATED COAGULATION FACTORS AND THE ATRIAL INFLAMMASOME	17
PE-534544-005 LONG-TERM ARRHYTHMIA AFTER CONE REPAIR OF EBSTEIN ANOMALY IN PEDIATRIC PATIENTS	17
PO-01-337 NONINVASIVE NEUECG CAPTURES DIET INDUCED SYMPATHETIC DYSFUNCTION WITH HISTOLOGIC CONFIRMATION IN THE STELLATE GANGLION	17
CI-534529-001 RETRIEVAL EXPERIENCE OF DUAL-CHAMBER, HELIX-FIXATION LEADLESS PACEMAKERS	17
PO-05-019 BEYOND VASOSPASM: PVC-INITIATED POLYMORPHIC VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION STORM AFTER 5-FLUOROURACIL THERAPY	17
Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial	16
Evaluation of noninvasive isochronal late activation mapping in scar-related ventricular tachycardia with electrocardiographic imaging against contact mapping	16
PO-02-333 ATRIAL GENE THERAPY TARGETING PARASYMPATHETIC SIGNALING RESULTS IN ELECTROGRAM RECURRENCE INCREASE INDICATING STABILIZATION OF ROTATIONAL DRIVERS IN ATRIAL FIBRILLATION CANINE MODEL	16
PO-04-329 IMPACT OF VERICIGUAT ON VENTRICULAR AND ATRIAL ARRHYTHMIC OUTCOMES IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	16
PO-CES-08 AI-ENABLED ECG PREDICTS FUTURE ONSET OF ATRIAL ARRHYTHMIAS IN PEDIATRIC AND CONGENITAL HEART DISEASE	16
Heart Rhythm 2026 Abstract Reviewers	16
Safety of magnetic resonance imaging in patients with surgically implanted permanent epicardial leads	16
Management strategies to prevent stroke in patients with atrial fibrillation and malignant left atrial appendage	16
PO-02-163 IMPACT OF TRANSTHORACIC ECHOCARDIOGRAPHIC PARAMETERS ON THE RISK FOR LEFT ATRIAL APPENDAGE THROMBUS: A RETROSPECTIVE COHORT STUDY	16
PO-02-093 DOES ATRIAL ECTOPY PREDICT ATRIAL FIBRILLATION RECURRENCE POST-ABLATION? A RETROSPECTIVE OBSERVATIONAL STUDY	16
PO-FPII-298 NOVEL FIXED HELIX STYLET DRIVEN LEAD FOR LBBAP: SHORT-TERM SAFETY AND PERFORMANCE OF THE SOLIA CSP S PACEMAKER LEAD	16
PO-02-203 SUCCESSFUL ABLATION OF ELECTRICAL STORM IN BURNT-OUT ARVC WITHOUT HEMODYNAMIC SUPPORT	16
Features and electrophysiologic behavior of AV nodal structure potential recorded in humans	16
PO-05-283 FIRST-IN-HUMAN EXPERIENCE AND SIX-MONTH OUTCOMES USING A NOVEL SMALL-BALLOON PULSED-FIELD ABLATION CATHETER IN PERSISTENT ATRIAL FIBRILLATION	16
PO-03-151 ARRHYTHMIA AND QT PROLONGATION PROFILE OF OSIMERTINIB IN EGFR-MUTATED LUNG CANCER: A PROPENSITY-MATCHED REAL-WORLD ANALYSIS	16
PO-05-040 ELECTRICAL DATA AND EGM MORPHOLOGY WITH ACUTE THROMBUS FORMATION ON HELIX OF LEADLESS VENTRICULAR PACEMAKERS	16
PO-02-103 LONG-TERM FOLLOW-UP OF CARDIAC SYMPATHETIC DENERVATION FOR REFRACTORY VENTRICULAR ARRHYTHMIAS: A SINGLE-CENTER RETROSPECTIVE STUDY	16
PO-02-239 IT’S JUST, A LITTLE TOUCH…PERMANENT MECHANICAL EFFECT ON AN UNUSUAL ATRIAL FOCUS IN A CHILD	16
Long-term outcomes of left bundle branch area pacing compared with right ventricular pacing in TAVI patients	15
To the Editor— Phrenic nerve injury after pulsed-field ablation: Quantification of symptom burden	15
Spatial ventricular gradient is associated with pacing-induced cardiomyopathy	15
Performance of cardiac implantable electronic devices in detecting premature ventricular contraction burden	15
Endothelial function improvement and the outcomes after catheter ablation of persistent atrial fibrillation	15
Single Antiplatelet Therapy vs Oral Anticoagulation Monotherapy in Patients With Atrial Fibrillation and Coronary Artery Disease After Successful Catheter Ablation: A Target Trial Emulation	15
Arrhythmia substrates accessible from the aortic root and immediate sub-aortic areas: Mapping and ablation	15
PO-07-216 EVALUATING SAFETY PROFILE AND LEARNING CURVE WITH A PULSED FIELD ABLATION VARIABLE LOOP CIRCULAR CATHETER IN PROCEDURES FOR AF: OBSERVATIONS FROM A PROSPECTIVE, MULTICENTER, POSTMARKET CLINI	15
Focal monopolar pulsed field ablation from within the great cardiac vein for idiopathic premature ventricular contractions after failed radiofrequency ablation	15
PO-06-045 LEFT BUNDLE BRANCH AREA PACING VERSUS RIGHT VENTRICULAR PACING IN POST-TAVR PATIENTS: A RETROSPECTIVE PROPENSITY-MATCHED ANALYSIS	15
Impact of left atrial posterior wall isolation using pulsed-field ablation in patients undergoing repeat catheter ablation for atrial fibrillation	15
Electrophysiologic characteristics and durability of index pulsed field ablation lesions from redo procedures for atrial arrhythmia recurrences	15
Comparison of left atrial appendage occlusion using transesophageal echocardiography vs 3-dimensional intracardiac echocardiography: Insights from a single-center NCDR registry	15
Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation	15
Association of frailty with outcomes of patients undergoing transvenous lead removal for cardiac implantable electronic device infections in the United States	15
14-3-3ε/YWHAE regulates the transcriptional expression of cardiac sodium channel NaV1.5	15
18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context	15
PO-FP-011 DETECTION OF ACUTE-ELECTRICALLY SILENT GAPS IN LESION USING A UNIPOLAR LOCAL SIGNAL ENERGY ALGORITHM IN A PORCINE MODEL OF PULMONARY VEIN PF OR RF ISOLATION	15
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome	15
Pulsed field ablation for incessant scar-related ventricular tachycardia: First US report	15
The anatomy of atrial conduction: A review of anatomic landmarks integrated with computed tomographic virtual dissection to provide a road map for right atrial pacing	15
Burden-based outcomes after atrial fibrillation ablation: A 4-year continuous monitoring study	15
Establishing a national cardiopulmonary resuscitation program in Indian high schools and colleges: An expert collaborative call to action and implementation model	15
PO-04-062 NATIONWIDE ANALYSIS OF IN-HOSPITAL OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND HFPEF	14
PO-04-123 BIOMARKERS IN EARLY AND LATE PERIOD AFTER RADIOFREQUENCY AND PULSED FIELD CATHETER ABLATION OF ATRIAL FIBRILLATION	14
PO-04-132 DISTRIBUTION AND TEMPORAL PROGRESSION OF LEFT ATRIAL POSTERIOR WALL (PW) LOW-VOLTAGE AREAS (LVA)	14
PO-03-001 ARTIFICIAL INTELLIGENCE FOR IMPROVED ATRIAL FLUTTER/ATRIAL TACHYCARDIA DETECTION IN INSERTABLE CARDIAC MONITOR	14
PO-04-144 ABLATION LESIONS THEMSELVES CAN LEAD TO ATRIAL FIBRILLATION (AF) RECURRENCE: A STUDY EMPLOYING PERSONALIZED DIGITAL TWINS (DTS) DERIVED FROM LATE GADOLINIUM ENHANCEMENT (LGE) MRIS	14
PO-02-034 CARDIOGENIC SHOCK AND PNEUMOPERICARDIUM: A RARE PRESENTATION OF ATRIOESOPHAGEAL FISTULA	14
PO-03-043 TRANS-BAFFLE INSERTION OF A LEADLESS PACEMAKER IN A PATIENT WITH EXTRACARDIAC FONTAN	14
PO-02-138 CAVOTRICUSPID ISTHMUS ABLATION USING A NOVEL SINGLE-SHOT LINEAR HEXAPOLAR PULSED FIELD ABLATION CATHETER SYSTEM	14
PO-05-181 EPICARDIAL CONDUCTION VELOCITY AND ANISOTROPIC PROPERTIES OF FIBRILLATION WAVES IN PATIENTS WITH ACUTELY INDUCED AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION	14
PO-05-096 LEARNING BEFORE BURNING: IMPACT OF SIMULATOR EXPOSURE ON CLINICAL ELECTROPHYSIOLOGY EDUCATION	14
PO-05-006 THE RIGHT VENTRICULAR OUTFLOW TRACT DISPLAYS A SMALL L-TYPE CALCIUM CURRENT AND TRANSIENT AMPLITUDE DUE TO A UNIQUE GENE EXPRESSION PROFILE INVOLVING SYT1	14
PO-04-127 COLCHICINE TREATMENT PREVENTS ATRIAL FIBRILLATION INCIDENCE IN A RAT MODEL OF CATHETER ABLATION: IDENTIFICATION OF SEX-SPECIFIC DIFFERENCES	14